Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Genomic epidemiology of CVA10 in Guangdong, China, 2013-2021.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X (Electronic) Linking ISSN: 1743422X NLM ISO Abbreviation: Virol J Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: [London] : BioMed Central, 2004-
    • الموضوع:
    • نبذة مختصرة :
      Hand, Foot and Mouth Disease (HFMD) is a highly contagious viral illness primarily affecting children globally. A significant epidemiological transition has been noted in mainland China, characterized by a substantial increase in HFMD cases caused by non-Enterovirus A71 (EV-A71) and non-Coxsackievirus A16 (CVA16) enteroviruses (EVs). Our study conducts a retrospective examination of 36,461 EV-positive specimens collected from Guangdong, China, from 2013 to 2021. Epidemiological trends suggest that, following 2013, Coxsackievirus A6 (CVA6) and Coxsackievirus A10 (CVA10) have emerged as the primary etiological agents for HFMD. In stark contrast, the incidence of EV-A71 has sharply declined, nearing extinction after 2018. Notably, cases of CVA10 infection were considerably younger, with a median age of 1.8 years, compared to 2.3 years for those with EV-A71 infections, possibly indicating accumulated EV-A71-specific herd immunity among young children. Through extensive genomic sequencing and analysis, we identified the N136D mutation in the 2 A protein, contributing to a predominant subcluster within genogroup C of CVA10 circulating in Guangdong since 2017. Additionally, a high frequency of recombination events was observed in genogroup F of CVA10, suggesting that the prevalence of this lineage might be underrecognized. The dynamic landscape of EV genotypes, along with their potential to cause outbreaks, underscores the need to broaden surveillance efforts to include a more diverse spectrum of EV genotypes. Moreover, given the shifting dominance of EV genotypes, it may be prudent to re-evaluate and optimize existing vaccination strategies, which are currently focused primarily target EV-A71.
      (© 2024. The Author(s).)
    • References:
      BMC Infect Dis. 2018 Dec 6;18(1):630. (PMID: 30522440)
      Arch Virol. 2013 Jan;158(1):211-5. (PMID: 22975986)
      Clin Microbiol Infect. 2014 Jul;20(7):O442-5. (PMID: 24428125)
      J Virol. 2004 Jan;78(2):855-67. (PMID: 14694117)
      PLoS One. 2017 May 9;12(5):e0176604. (PMID: 28486500)
      PLoS One. 2014 Jan 02;9(1):e84233. (PMID: 24392117)
      Bioinformatics. 2018 Dec 1;34(23):4121-4123. (PMID: 29790939)
      PLoS One. 2016 Oct 5;11(10):e0163962. (PMID: 27706213)
      Clin Microbiol Infect. 2012 May;18(5):E110-8. (PMID: 22404077)
      Front Microbiol. 2022 Jan 06;12:811553. (PMID: 35069515)
      Rev Med Virol. 2018 Nov;28(6):e2002. (PMID: 30069956)
      J Virol. 1999 Oct;73(10):8741-9. (PMID: 10482628)
      Virus Res. 2018 Jan 15;244:262-269. (PMID: 29175108)
      Infect Genet Evol. 2018 Dec;66:101-110. (PMID: 30217658)
      Ann N Y Acad Sci. 1953 Mar 31;56(3):583-6. (PMID: 13139263)
      Mol Biol Evol. 2013 Apr;30(4):772-80. (PMID: 23329690)
      J Infect. 2018 Aug;77(2):158-164. (PMID: 29746947)
      Virus Evol. 2018 Jan 08;4(1):vex042. (PMID: 29340210)
      Virus Evol. 2020 May 10;6(1):veaa029. (PMID: 32411392)
      Antiviral Res. 2016 May;129:58-66. (PMID: 26899790)
      Int J Infect Dis. 2010 Dec;14(12):e1076-81. (PMID: 20952237)
      Sci Rep. 2018 Sep 6;8(1):13357. (PMID: 30190558)
      J Med Virol. 2022 Feb;94(2):601-609. (PMID: 34387895)
      PLoS Negl Trop Dis. 2021 Feb 10;15(2):e0008885. (PMID: 33566802)
      J Virol. 1999 Jan;73(1):152-60. (PMID: 9847317)
      J Clin Virol. 2017 Aug;93:20-24. (PMID: 28577423)
      Expert Rev Anti Infect Ther. 2019 Apr;17(4):233-242. (PMID: 30793637)
      Virology. 2006 Feb 20;345(2):346-57. (PMID: 16297952)
      Virol Sin. 2022 Apr;37(2):177-186. (PMID: 35234621)
      Mol Biol Evol. 2015 Jan;32(1):268-74. (PMID: 25371430)
      PLoS One. 2015 Nov 12;10(11):e0142733. (PMID: 26562154)
      J Clin Microbiol. 1999 May;37(5):1288-93. (PMID: 10203472)
      Sci Rep. 2015 May 21;5:10550. (PMID: 25993899)
      J Virol. 2010 Apr;84(7):3339-50. (PMID: 20089660)
      PLoS One. 2015 Sep 23;10(9):e0138514. (PMID: 26398767)
    • Contributed Indexing:
      Keywords: Coxsackievirus A10; Enterovirus; Epidemiology; Foot and mouth disease; Hand; Phylogenetic
    • الموضوع:
      Date Created: 20240530 Date Completed: 20240531 Latest Revision: 20240603
    • الموضوع:
      20240603
    • الرقم المعرف:
      PMC11140982
    • الرقم المعرف:
      10.1186/s12985-024-02389-9
    • الرقم المعرف:
      38816865